Germinal center function in the spleen during simian HIV infection in rhesus monkeys

Journal of Immunology

Volumn 177, Issue 2, 2006, Pages 1108-1119

  Margolin, David H ^a,c   Saunders, Erika H ^a,d   Bronfin, Benjamin ^a   De Rosa, Nicole ^a,e   Axthelm, Michael K ^b   Goloubeva, Olga G ^a   Eapen, Sara ^a   Gelman, Rebecca S ^a   Letvin, Norman L ^a,f  

^a HARVARD MEDICAL SCHOOL   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^f BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; ANTIBODY; COMPLEMENTARY DNA; CYTOSINE; ENVELOPE PROTEIN; GLYCOPROTEIN GP 120; GUANINE; IMMUNOGLOBULIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN J CHAIN; THYMINE; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY AFFINITY; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ARTICLE; B LYMPHOCYTE; CELL ISOLATION; CELL LINEAGE; CLONE; COMPLEMENTARITY DETERMINING REGION; FROZEN SECTION; GENE MUTATION; GENE SEQUENCE; GERMINAL CENTER; HISTOPATHOLOGY; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOGLOBULIN STRUCTURE; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOHISTOCHEMISTRY; LASER CAPTURE MICRODISSECTION; MACACA; MOLECULAR CLONING; MUTATION RATE; NONHUMAN; NUCLEOTIDE SEQUENCE; OLIGONUCLEOTIDE PROBE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RHESUS MONKEY; SEQUENCE ANALYSIS; SILENT MUTATION; SIMIAN IMMUNODEFICIENCY VIRUS; SOMATIC MUTATION; SPLEEN; TRANSITION MUTATION; TRANSVERSION MUTATION; VIRUS RECOMBINANT;

EID: 33745858007     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.2.1108     Document Type: Article

References (76)

1. Racz, P., K. Tenner-Racz, F. van Vloten, H. Schmidt, M. Dietrich, J. C. Gluckman, N. L. Letvin, and G. Janossy. 1990. Lymphatic tissue changes in AIDS and other retrovirus infections: tools and insights. Lymphology 23: 85-91.
2. Chalifoux, L. V., N. W. King, and N. L. Letvin. 1984. Morphologic changes in lymph nodes of macaques with an immunodeficiency syndrome. Lab. Invest. 51: 22-26.
3. H rearrangements. Immunol. Rev. 162: 161-171.
4. Neuberger, M. S., M. R. Ehrenstein, N. Klix, C. J. Jolly, J. Yelamos, C. Rada, and C. Milstein. 1998. Monitoring and interpreting the intrinsic features of somatic hypermutation. Immunol. Rev. 162: 107-116.
5. Levy, Y., N. Gupta, F. Le Deist, C. Garcia, A. Fischer, J. C. Weill, C. A. Reynaud, B. Bertocci, L. Quint, F. Delbos, et al. 1998. Defect in IgV gene somatic hypermutation in common variable immuno-deficiency syndrome. Proc. Natl. Acad. Sci. USA 95: 13135-13140.
6. Manheimer-Lory, A. J., G. Zandman-Goddard, A. Davidson, C. Aranow, and B. Diamond. 1997. Lupus-specific antibodies reveal an altered pattern of somatic mutation. J. Clin. Invest. 100: 2538-2546.
7. Dorner, T., S. Kaschner, A. Hansen, A. Pruss, and P. E. Lipsky. 2001. Perturbations in the impact of mutational activity on VA genes in systemic lupus erythematosus. Arthritis Res. 3: 368-374.
8. Revy, P., T. Muto, Y. Levy, F. Geissmann, A. Plebani, O. Sanal, N. Catalan, M. Forveille, R. Dufourcq-Labelouse, A. Gennery, et al. 2000. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the hyper-IgM syndrome (HIGM2). Cell 102: 565-575.
9. Zeng, X., D. B. Winter, C. Kasmer, K. H. Kraemer, A. R. Lehmann, and P. J. Gearhart. 2001. DNA polymerase eta is an A-T mutator in somatic hypermutation of immunoglobulin variable genes. Nat. Immunol. 2: 537-541.
10. Mascola, J. R., G. Stiegler, T. C. VanCott, H. Katinger, C. B. Carpenter, C. E. Hanson, H. Beary, D. Hayes, S. S. Frankel, D. L. Birx, and M. G. Lewis. 2000. Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Nat. Med. 6: 207-210.
11. Shibata, R., T. Igarashi, N. Haigwood, A. Buckler-White, R. Ogert, W. Ross, R. Willey, M. W. Cho, and M. A. Martin. 1999. Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys. Nat. Med. 5: 204-210.
12. Mascola, J. R., M. G. Lewis, G. Stiegler, D. Harris, T. C. VanCott, D. Hayes, M. K. Louder, C. R. Brown, C. V. Sapan, S. S. Frankel, et al. 1999. Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies. J. Virol. 73: 4009-4018.
13. Emini, E. A., W. A. Schleif, J. H. Nunberg, A. J. Conley, Y. Eda, S. Tokiyoshi, S. D. Putney, S. Matsushita, K. E. Cobb, C. M. Jett, et al. 1992. Prevention of HIV-1 infection in chimpanzees by gp120 V3 domain-specific monoclonal antibody. Nature 355: 728-730.
14. Conley, A. J., J. A. Kessler, II, L. J. Boots, P. M. McKenna, W. A. Schleif, E. A. Emini, G. E. Mark, III, H. Katinger, E. K. Cobb, S. M. Lunceford, et al. 1996. The consequence of passive administration of an anti-human immunodeficiency virus type 1 neutralizing monoclonal antibody before challenge of chim-panzees with a primary virus isolate. J. Virol. 70: 6751-6758.
15. Wei, X., J. M. Decker, S. Wang, H. Hui, J. C. Kappes, X. Wu, J. F. Salazar-Gonzalez, M. G. Salazar, J. M. Kilby, M. S. Saag, et al. 2003. Antibody neutralization and escape by HIV-1. Nature 422: 307-312.
16. Richman, D. D., T. Wrin, S. J. Little, and C. J. Petropoulos. 2003. Rapid evolution of the neutralizing antibody response to HIV type 1 infection. Proc. Natl. Acad. Sci. USA 100: 4144-4149.
17. McKeating, J. A., J. Gow, J. Goudsmit, L. H. Pearl, C. Mulder, and R. A. Weiss. 1989. Characterization of HIV-1 neutralization escape mutants. AIDS 3: 777-784.
18. Burns, D. P., C. Collignon, and R. C. Desrosiers. 1993. Simian immunodeficiency virus mutants resistant to serum neutralization arise during persistent infection of rhesus monkeys. J. Virol. 67: 4104-4113.
19. Nara, P., L. Smit, N. Dunlop, W. Hatch, M. Merges, D. Waters, J. Kelliher, W. Krone, and J. Goudsmit. 1990. Evidence for rapid selection and deletion of HIV-1 subpopulations in vivo by V3-specific neutralizing antibody: a model of humoral-associated selection. Dev. Biol. Stand. 72: 315-341.
20. Cheng-Mayer, C., A. Brown, J. Harouse, P. A. Luciw, and A. J. Mayer. 1999. Selection for neutralization resistance of the simian/human immunodeficiency virus SHIVSF33A variant in vivo by virtue of sequence changes in the extracellular envelope glycoprotein that modify N-linked glycosylation. J. Virol. 73: 5294-5300.
21. Evans, D. T., and R. C. Desrosiers. 2001. Immune evasion strategies of the primate lentiviruses. Immunol. Rev. 183: 141-158.
22. Arendrup, M., A. Sonnerborg, B. Svennerholm, L. Akerblom, C. Nielsen, H. Clausen, S. Olofsson, J. O. Nielsen, and J. E. Hansen. 1993. Neutralizing antibody response during human immunodeficiency virus type 1 infection: type and group specificity and viral escape. J. Gen. Virol. 74: 855-863.
23. Chackerian, B., L. M. Rudensey, and J. Overbaugh. 1997. Specific N-linked and O-linked glycosylation modifications in the envelope V1 domain of simian immunodeficiency virus variants that evolve in the host alter recognition by neutralizing antibodies. J. Virol. 71: 7719-7727.
24. + T-cell-depleted macaques. AIDS 16: 829-838.
25. Schmitz, J. E., M. J. Kuroda, S. Santra, M. A. Simon, M. A. Lifton, W. Lin, R. Khunkhun, M. Piatak, J. D. Lifson, G. Grosschupff, et al. 2003. Effect of humoral immune responses on controlling viremia during primary infection of rhesus monkeys with simian immunodeficiency virus. J. Virol. 77: 2165-2173.
26. Binley, J. M., B. Clas, A. Gettie, M. Vesanen, D. C. Montefiori, L. Sawyer, J. Booth, M. Lewis, P. A. Marx, S. Bonhoeffer, and J. P. Moore. 2000. Passive infusion of immune serum into simian immunodeficiency virus-infected rhesus macaques undergoing a rapid disease course has minimal effect on plasma viremia. Virology 270: 237-249.
27. Arendrup, M., C. Nielsen, J. E. Hansen, C. Pedersen, L. Mathiesen, and J. O. Nielsen. 1992. Autologous HIV-1 neutralizing antibodies: emergence of neutralization-resistant escape virus and subsequent development of escape virus neutralizing antibodies. J. Acquir. Immune Defic. Syndr. 5: 303-307.
28. Moog, C., H. J. Fleury, I. Pellegrin, A. Kirn, and A. M. Aubertin. 1997. Autologous and heterologous neutralizing antibody responses following initial seroconversion in human immunodeficiency virus type 1-infected individuals. J. Virol. 71: 3734-3741.
29. Clements, J. E., R. C. Montelaro, M. C. Zink, A. M. Amedee, S. Miller, A. M. Trichel, B. Jagerski, D. Hauer, L. N. Martin, R. P. Bohm, et al. 1995. Cross-protective immune responses induced in rhesus macaques by immunization with attenuated macrophage-tropic simian immunodeficiency virus. J. Virol. 69: 2737-2744.
30. Cole, K. S., J. L. Rowles, B. A. Jagerski, M. Murphey-Corb, T. Unangst, J. E. Clements, J. Robinson, M. S. Wyand, R. C. Desrosiers, and R. C. Montelaro. 1997. Evolution of envelope-specific antibody responses in monkeys experimentally infected or immunized with simian immunodeficiency virus and its association with the development of protective immunity. J. Virol. 71: 5069-5079.
31. Pilgrim, A. K., G. Pantaleo, O. J. Cohen, L. M. Fink, J. Y. Zhou, J. T. Zhou, D. P. Bolognesi, A. S. Fauci, and D. C. Montefiori. 1997. Neutralizing antibody responses to human immunodeficiency virus type 1 in primary infection and long-term-nonprogressive infection. J. Infect. Dis. 176: 924-932.
32. Wrin, T., L. Crawford, L. Sawyer, P. Weber, H. W. Sheppard, and C. V. Hanson. 1994. Neutralizing antibody responses to autologous and heterologous isolates of human immunodeficiency virus. J. Acquir. Immune Defic. Syndr. 7: 211-219.
33. Quinnan, G. V., Jr., P. F. Zhang, D. W. Fu, M. Dong, and J. B. Margolick. 1998. Evolution of neutralizing antibody response against HIV type 1 virions and pseudovirions in multicenter AIDS cohort study participants. AIDS Res. Hum. Retroviruses 14: 939-949.
34. Zhang, Z. Q., W. A. Schleif, D. R. Casimiro, L. Handt, M. Chen, M. E. Davies, X. Liang, T. M. Fu, A. Tang, K. A. Wilson, et al. 2004. The impact of early immune destruction on the kinetics of postacute viral replication in rhesus monkey infected with the simian-human immunodeficiency virus 89.6P. Virology 320: 75-84.
35. Joag, S. V. 2000. Primate models of AIDS. Microbes Infect. 2: 223-229.
36. H3 family in rhesus monkeys. Immunogenetics 51: 519-527.
37. H4-21 (V4-34). Mol. Immunol. 34: 237-253.
38. Link, J. M., M. A. Hellinger, and H. W. Schroeder, Jr. 2002. The Rhesus monkey immunoglobulin IGHD and IGHJ germline repertoire. Immunogenetics 54: 240-250.
39. HVI) throughout primate evolution. J. Immunol 146: 2434-2438.
40. Bible, J. M., W. Howard, H. Robbins, and D. K. Dunn-Walters. 2003. IGHV1, IGHV5 and IGHV7 subgroup genes in the rhesus macaque. Immunogenetics 54: 867-873.
41. Ermert, K., H. Mitlohner, W. Schempp, and H. G. Zachau. 1995. The immunoglobulin κ locus of primates. Genomics 25: 623-629.
42. Margolin, D. H., E. F. Helmuth Saunders, B. Bronfin, N. de Rosa, M. K. Axthelm, X. Alvarez, and N. L. Letvin. 2002. High frequency of virus-specific B lymphocytes in germinal centers of SHIV-infected rhesus monkeys. J. Virol. 76: 3965-3973.
43. Baik, S. S., R. W. Doms, and B. J. Doranz. 1999. HIV and SIV gp120 binding does not predict coreceptor function. Virology 259: 267-273.
44. Broder, C. C., P. L. Earl, D. Long, S. T. Abedon, B. Moss, and R. W. Doms. 1994. Antigenic implications of human immunodeficiency virus type 1 envelope quaternary structure: oligomer-specific and -sensitive monoclonal antibodies. Proc. Natl. Acad. Sci. USA 91: 11699-11703.
45. + T-cell depletion in macaques infected by a simian-human immunodeficiency virus. J. Virol. 75: 5646-5655.
46. Reimann, K. A., J. T. Li, R. Veazey, M. Halloran, I.-W. Park, G. B. Karlsson, J. Sodroski, and N. L. Letvin. 1996. A chimeric simian/human immunodeficiency virus expressing a primary patient HIV-1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys. J. Virol. 70: 6922-6928.
47. + T lymphocyte depletion in simian-human immunodeficiency virus-infected macaques. J. Exp. Med. 188: 1159-1171.
48. 1996. Guide for the Care and Use of Laboratory Animals. National Research Council, National Academy Press, Washington, DC.
49. Bonner, R. F., M. Emmert-Buck, K. Cole, T. Pohida, R. Chuaqui, S. Goldstein, and L. A. Liotta. 1997. Laser capture microdissection: molecular analysis of tissue. Science 278: 1481-1483.
50. Lefranc, M. P. 2001. IMGT, the international ImMunoGeneTics database. Nucleic Acids Res. 29: 207-209.
51. Nei, M., and T. Gojobori. 1986. Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol. Biol. Evol. 3: 418-426.
52. Ota, T., and M. Nei. 1994. Variance and covariances of the numbers of synonymous and nonsynonymous substitutions per site. Mol. Biol. Evol. 11: 613-619.
53. Korber, B. T. 2000. HIV signature and sequence variation analysis. In Computational and Evolutionary Analysis of HIV Molecular Sequences. A. G. Rodrigo and G. H. Learn, eds. Kluwer Academic Publishers, Dordrecht, pp. 55-72.
54. Lossos, I. S., R. Tibshirani, B. Narasimhan, and R. Levy. 2000. The inference of antigen selection on Ig genes. J. Immunol. 165: 5122-5126.
55. Rogozin, I. B., and N. A. Kolchanov. 1992. Somatic hypermutagenesis in immunoglobulin genes. II. Influence of neighbouring base sequences on mutagenesis. Biochim. Biophys. Acta 1171: 11-18.
56. Betz, A. G., M. S. Neuberger, and C. Milstein. 1993. Discriminating intrinsic and antigen-selected mutational hotspots in immunoglobulin V genes. Immunol. Today 14: 405-411.
57. Rada, C., G. T. Williams, H. Nilsen, D. E. Barnes, T. Lindahl, and M. S. Neuberger. 2002. Immunoglobulin isotype switching is inhibited and somatic hypermutation perturbed in UNO-deficient mice. Curr. Biol. 12: 1748-1755.
58. Barbas, C. F., T. A. Collet, W. Amberg, P. Roben, J. M. Binley, D. Hoekstra, D. Cababa, T. M. Jones, R. A. Williamson, G. R. Pilkington, et al. 1993. Molecular profile of an antibody response to HIV-1 as probed by combinatorial libraries. J. Mol. Biol. 230: 812-823.
59. Toran, J. L., L. Kremer, L. Sanchez-Pulido, I. M. de Alboran, G. del Real, M. Llorente, A. Valencia, M. A. de Mon, and A. C. Martinez. 1999. Molecular analysis of HIV-1 gp120 antibody response using isotype IgM and IgG phage display libraries from a long-term non-progressor HIV-1-infected individual. Eur. J. Immunol. 29: 2666-2675.
60. Cavacini, L. A., C. L. Emes, A. V. Wisnewski, J. Power, G. Lewis, D. Montefiori, and M. R. Posner. 1998. Functional and molecular characterization of human monoclonal antibody reactive with the immunodominant region of HIV type 1 glycoprotein 41. AIDS Res. Hum. Retroviruses 14: 1271-1280.
61. Bagley, J., P. J. Dillon, C. Rosen, J. Robinson, J. Sodroski, and W. A. Marasco. 1994. Structural characterization of broadly neutralizing human monoclonal antibodies against the CD4 binding site of HIV-1 gp120. Mol. Immunol. 31: 1149-1160.
62. David, D., and M. Zouali. 1995. Variable region light chain genes encoding human antibodies to HIV-1. Mol. Immunol. 32: 77-88.
63. Moran, M. J., J. S. Andris, Y.-I. Matsumato, J. D. Capra, and E. M. Hersh. 1993. Variable region genes of anti-HIV human monoclonal antibodies: non-restricted use of the V gene repertoire and extensive somatic mutation. Mol. Immunol. 30: 1543-1551.
64. Kunert, R., F. Ruker, and H. Katinger. 1998. Molecular characterization of five neutralizing anti-HIV type 1 antibodies: identification of nonconventional D segments in the human monoclonal antibodies 2G12 and 2F5. AIDS Res. Hum. Retroviruses 14: 1115-1128.
65. Pascual, V., Y.-J. Liu, A. Magalski, O. de Bouteiller, J. Banchereau, and J. D. Capra. 1994. Analysis of somatic mutation in five B cell subsets of human tonsil. J. Exp. Med. 180: 329-339.
66. Clarke, S. H., K. Huppi, D. Ruezinsky, L. Staudt, W. Gerhard, and M. Weigert. 1985. Inter- and intraclonal diversity in the antibody response to influenza haemagglutinin. J. Exp. Med. 161: 687-704.
67. Jacob, J., J. Przylepa, C. Miller, and G. Kelsoe. 1993. In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. III. The kinetics of V region mutation and selection in germinal center B cells. J. Exp. Med. 178: 1293-1307.
68. Liu, Y. J., J. Zhang, P. J. Lane, E. Y. Chan, and I. C. MacLennan. 1991. Sites of specific B cell activation in primary and secondary responses to T cell-dependent and T cell-independent antigens. Eur. J. Immunol. 21: 2951-2962.
69. Jacob, J., R. Kassir, and G. Kelsoe. 1991. In situ studies of the primary immune response to (4-hydroxy-3- nitrophenyl)acetyl. I. The architecture and dynamics of responding cell populations. J. Exp. Med. 173: 1165-1175.
70. Feinberg, M. B., and J. P. Moore. 2002. AIDS vaccine models: challenging challenge viruses. Nat. Med. 8: 207-210.
71. Andris, J. S., P. H. Ehrlich, L. Ostberg, and J. D. Capra. 1992. Probing the human antibody repertoire to exogenous antigens: characterization of the H and L chain V region gene segments from anti-hepatitis B virus antibodies. J. Immunol. 149: 4053-4059.
72. Sakurai, H., R. A. Williamson, J. E. Crowe, J. A. Beeler, P. Poignard, R. B. Bastidas, R. M. Chanock, and D. R. Burton. 1999. Human antibody responses to mature and immature forms of viral envelope in respiratory syncytial virus infection: significance for subunit vaccines. J. Virol. 73: 2956-2962.
73. L kv325 immunoglobulin gene combination in hepatitis C virus-associated immunocytomas. Blood 91: 2433-2442.
74. William, J., C. Euler, S. Christensen, and M. J. Shlomchik. 2002. Evolution of autoantibody responses via somatic hypermutation outside of germinal centers. Science 297: 2066-2070.
75. Matsumoto, M., S. F. Lo, C. J. Carruthers, J. Min, S. Mariathasan, G. Huang, D. R. Plas, S. M. Martin, R. S. Geha, M. H. Nahm, and D. D. Chaplin. 1996. Affinity maturation without germinal centres in lymphotoxin-α- deficient mice. Nature 382: 462-466.
76. Takahashi, Y., P. R. Dutta, D. M. Cerasoli, and G. Kelsoe. 1998. In situ studies of the primary immune response to (4-hydroxy-3- nitrophenyl)acetyl. V. Affinity maturation develops in two stages of clonal selection. J. Exp. Med. 187: 885-895.